Compare · EBAY vs OPRX
EBAY vs OPRX
Side-by-side comparison of eBay Inc. (EBAY) and OptimizeRx Corporation (OPRX): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both EBAY and OPRX operate in Real Estate (Real Estate), so they compete in similar markets.
- EBAY is the larger of the two at $49.87B, about 397.2x OPRX ($125.5M).
- Over the past year, EBAY is up 41.8% and OPRX is down 47.9% - EBAY leads by 89.7 points.
- EBAY has been more active in the news (2 items in the past 4 weeks vs 1 for OPRX).
- EBAY has more recent analyst coverage (25 ratings vs 11 for OPRX).
- Company
- eBay Inc.
- OptimizeRx Corporation
- Price
- $112.03+1.03%
- $6.71+0.75%
- Market cap
- $49.87B
- $125.5M
- 1M return
- +2.57%
- +27.08%
- 1Y return
- +41.76%
- -47.90%
- Industry
- Real Estate
- Real Estate
- Exchange
- NASDAQ
- NASDAQ
- IPO
- 1998
- News (4w)
- 2
- 1
- Recent ratings
- 25
- 11
eBay Inc.
eBay Inc. operates marketplace platforms that connect buyers and sellers worldwide. The company's Marketplace platform includes its online marketplace at ebay.com and the eBay suite of mobile apps. Its platforms enable users to list, buy, sell, and pay for items through various online, mobile, and offline channels that include retailers, distributors, liquidators, import and export companies, auctioneers, catalog and mail-order companies, classifieds, directories, search engines, commerce participants, shopping channels, and networks. eBay Inc. has a strategic partnership with Bidadoo, Inc. to transform heavy equipment industry. The company was founded in 1995 and is headquartered in San Jose, California.
OptimizeRx Corporation
OptimizeRx Corporation operates as a digital health company that provides communications solutions for life science companies, physicians, and patients. Its products and applications include financial messaging, a virtual patient support center that allows doctors and staff to access sample vouchers, co-pay coupons, and other patient support through their EMR and/or e-prescribe systems; and brand awareness and therapeutic support messaging services, such as brand awareness messages, reminder ads, therapeutic support messages, and unbranded messages. The company also offers brand support services, which focuses on educating and working with pharmaceutical manufacturers on identifying, formulating, and implementing new eRx media strategies, including drug file integration, sales force training, and strategy development services for promoting their products. In addition, it operates cloud based Mobile Health Messenger platform that provides interactive health messaging for enhanced medication adherence and care coordination; and HIPAA-compliant automated mobile messaging platform that allows pharmaceutical manufactures and related entities to directly engage with patients to enhance regimen compliance. Further, the company offers patient programs with treatment and affordability information, lifestyle and condition trackers, Internet device connectivity, forms, and surveys. OptimizeRx Corporation is headquartered in Rochester, Michigan.
Latest EBAY
- Wedbush resumed coverage on eBay with a new price target
- President and CEO Iannone Jamie sold $2,531,580 worth of shares (22,220 units at $113.93), decreasing direct ownership by 8% to 264,321 units (SEC Form 4)
- SVP, Chief Commercial Officer Sweetnam Jordan Douglas Bradley sold $94,214 worth of shares (863 units at $109.17) as part of a pre-agreed trading plan, decreasing direct ownership by 2% to 34,533 units (SEC Form 4)
- SVP, Chief Technology Officer Rawashdeh Mazen sold $208,231 worth of shares (1,919 units at $108.51) as part of a pre-agreed trading plan, decreasing direct ownership by 6% to 32,124 units (SEC Form 4)
- Director Traquina Perry M converted options into 3,355 shares, increasing direct ownership by 4% to 88,832 units (SEC Form 4)
- Director Shroff Mohak converted options into 3,355 shares, increasing direct ownership by 14% to 27,704 units (SEC Form 4)
- Director Sharples Brian converted options into 892 shares (SEC Form 4)
- Director Rowe Zane converted options into 3,355 shares, increasing direct ownership by 35% to 13,007 units (SEC Form 4)
- Director Ramanan Shripriya Mahesh converted options into 3,355 shares, increasing direct ownership by 33% to 13,668 units (SEC Form 4)
- Director Pressler Paul S converted options into 4,697 shares, increasing direct ownership by 5% to 99,903 units (SEC Form 4)
Latest OPRX
- OptimizeRx Launches CopayCue™, a Next-Generation Copay Activation Solution Powered by Real-Time Prescribing Intent
- OptimizeRx Launches Natural Language Audience Builder for Life Sciences DSPs and Agency Media Planning Platforms
- OptimizeRx Corporation filed SEC Form 8-K: Leadership Update, Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits
- Director Klema Cathy was granted 34,517 shares, increasing direct ownership by 160% to 56,137 units (SEC Form 4)
- Director Lang James Paul was granted 34,517 shares, increasing direct ownership by 9% to 433,837 units (SEC Form 4)
- Director Presti Mariyamma Varghese was granted 17,258 shares, increasing direct ownership by 132% to 30,318 units (SEC Form 4)
- Director Spangler Patrick D was granted 34,517 shares, increasing direct ownership by 78% to 78,732 units (SEC Form 4)
- Director Vos Ellen O'Connor was granted 34,517 shares, increasing direct ownership by 48% to 107,159 units (SEC Form 4)
- Director Wasson Gregory D was granted 34,517 shares, increasing direct ownership by 60% to 91,700 units (SEC Form 4)
- Director Presti Mariyamma Varghese was granted 13,060 shares (SEC Form 4)